摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5,8-dimethoxytetralin-2-carboxylic acid | 68569-97-1

中文名称
——
中文别名
——
英文名称
5,8-dimethoxytetralin-2-carboxylic acid
英文别名
5,8-dimethoxy-1,2,3,4-tetrahydronaphthalene-2-carboxylic acid
5,8-dimethoxytetralin-2-carboxylic acid化学式
CAS
68569-97-1
化学式
C13H16O4
mdl
——
分子量
236.268
InChiKey
CPWCICMLTNTXCU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    180-182 °C(Solv: ethyl acetate (141-78-6); hexane (110-54-3))
  • 沸点:
    450.9±45.0 °C(Predicted)
  • 密度:
    1.202±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    17
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.46
  • 拓扑面积:
    55.8
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Facile Total Syntheses of Idarubicinone‐7‐β‐D‐glucuronide: Convenient Preparations of AB‐Ring Synthon Using Some Carboxylic Acid Derivatives
    摘要:
    Regiospecific syntheses of idarubicinone coupled with D-glucuronic acid are described. Cyclization of dimethoxybenzene with carboxylic acid derivatives in polyphosphoric acid (PPA) in one step afforded the naphthalenones 7, which were transformed to the (+/-)-idarubicinone 3b by general methods. Esterification of (+/-)-3b with (S)-(+)-O-acetylmandelic acid with subsequent separation and deprotection gave (+)-3b and (-)-3b. Reaction of separated two stereoisomers with acetobromo-alpha-D-glucuronic acid methyl ester respective followed by hydrolysis using lithium hydroxide and amberite cation exchange resin furnished two kinds of idarubicinone-7-beta-D-glucuronide (20 and 21) that are coupled at C-7 position of idarubicinone.
    DOI:
    10.1081/scc-120030758
  • 作为产物:
    描述:
    参考文献:
    名称:
    Facile Total Syntheses of Idarubicinone‐7‐β‐D‐glucuronide: Convenient Preparations of AB‐Ring Synthon Using Some Carboxylic Acid Derivatives
    摘要:
    Regiospecific syntheses of idarubicinone coupled with D-glucuronic acid are described. Cyclization of dimethoxybenzene with carboxylic acid derivatives in polyphosphoric acid (PPA) in one step afforded the naphthalenones 7, which were transformed to the (+/-)-idarubicinone 3b by general methods. Esterification of (+/-)-3b with (S)-(+)-O-acetylmandelic acid with subsequent separation and deprotection gave (+)-3b and (-)-3b. Reaction of separated two stereoisomers with acetobromo-alpha-D-glucuronic acid methyl ester respective followed by hydrolysis using lithium hydroxide and amberite cation exchange resin furnished two kinds of idarubicinone-7-beta-D-glucuronide (20 and 21) that are coupled at C-7 position of idarubicinone.
    DOI:
    10.1081/scc-120030758
点击查看最新优质反应信息

文献信息

  • Composition for treatment of pathogens that are resistant to tetracyclines
    申请人:Bioversys AG
    公开号:EP2762134A1
    公开(公告)日:2014-08-06
    The invention relates to compounds and pharmaceutical compositions useful in combination with tetracyclines in the treatment of bacterial infections caused by Gram-positive and Gram-negative pathogens, with particular efficacy in tetracycline resistant strains. These compounds specifically bind to TetR and therefore prevent the transcriptional activation of tet resistance genes. The compounds have a potentiating effect on the activity of members of the tetracycline family, in particular of tetracycline, minocycline, doxycycline and tigecycline, in the treatment of tetracycline susceptible, intermediate and tetracycline resistant pathogens.
    该发明涉及与四环素结合在一起用于治疗由革兰氏阳性和革兰氏阴性病原体引起的细菌感染的化合物和药物组合物,对四环素耐药菌株尤为有效。这些化合物特异性地结合到TetR,从而阻止tet耐药基因的转录激活。这些化合物对四环素家族成员的活性具有增强作用,尤其对四环素、米诺环素、多西环素和替加环素在治疗四环素敏感、中间和四环素耐药病原体方面具有增强作用。
  • [EN] COMPOSITION FOR TREATMENT OF PATHOGENS THAT ARE RESISTANT TO TETRACYCLINES<br/>[FR] COMPOSITION POUR LE TRAITEMENT DE PATHOGÈNES QUI SONT RÉSISTANTS AUX TÉTRACYCLINES
    申请人:BIOVERSYS AG
    公开号:WO2014118361A1
    公开(公告)日:2014-08-07
    The invention relates to compounds and pharmaceutical compositions useful in combination with tetracyclines in the treatment of bacterial infections caused by Gram- positive and Gram-negative pathogens, with particular efficacy in tetracycline resistant strains. These compounds specifically bind to TetR and therefore prevent the transcriptional activation of tet resistance genes. The compounds have a potentiating effect on the activity of members of the tetracycline family, in particular of tetracycline, minocycline, doxycycline and tigecycline, in the treatment of tetracycline susceptible, intermediate and tetracycline resistant pathogens.
    该发明涉及与四环素联合使用的化合物和药物组合物,用于治疗由革兰氏阳性和革兰氏阴性病原体引起的细菌感染,特别在四环素耐药菌株中具有显著疗效。这些化合物特异性地结合到TetR,从而阻止tet耐药基因的转录激活。这些化合物对四环素家族成员(特别是四环素、米诺环素、多西环素和替吉环素)的活性具有增强作用,在治疗四环素敏感、中间和四环素耐药病原体方面表现出效果。
  • COMPOSITION FOR TREATMENT OF PATHOGENS THAT ARE RESISTANT TO TETRACYCLINES
    申请人:BIOVERSYS AG
    公开号:US20150359791A1
    公开(公告)日:2015-12-17
    The invention relates to compounds and pharmaceutical compositions useful in combination with tetracyclines in the treatment of bacterial infections caused by Gram-positive and Gram-negative pathogens, with particular efficacy in tetracycline resistant strains. These compounds specifically bind to TetR and therefore prevent the transcriptional activation of tet resistance genes. The compounds have a potentiating effect on the activity of members of the tetracycline family, in particular of tetracycline, minocycline, doxycycline and tigecycline, in the treatment of tetracycline susceptible, intermediate and tetracycline resistant pathogens.
    本发明涉及化合物和药物组合物,可用于与四环素联合治疗由革兰氏阳性和革兰氏阴性病原体引起的细菌感染,对四环素耐药菌株具有特殊疗效。这些化合物特异性结合TetR,从而防止tet耐药基因的转录激活。这些化合物对四环素家族成员的活性具有增强作用,特别是对四环素、米诺环素、多西环素和替加环素在四环素敏感、中间和四环素耐药病原体治疗中的活性具有增强作用。
  • Rao, M. Vishnumurthi; Bhatt, M. Vivekananda, Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 1981, vol. 20, # 6, p. 487 - 488
    作者:Rao, M. Vishnumurthi、Bhatt, M. Vivekananda
    DOI:——
    日期:——
  • Synthesis and redox properties of chromophore modified glycosides related to anthracyclines
    作者:J. William Lown、Sham M. Sondhi、Sukhendu B. Mandal、John Murphy
    DOI:10.1021/jo00143a026
    日期:1982.10
查看更多